TrialBMC gastroenterology2009

Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study.

Claudia Pena Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.